ARCHIVES

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

NCI program announcement available, contract awards listed.

November 14, 2003

DCT Board Okays Concepts For New Radiation Studies

June 12, 1987

Cancer Care Driven Toward: Triage” System, Puerto Rico Dean Tells AACI

July 21, 1989

Tracor Lands Second Biggest NCI Contract-$6.6 Million To Manage Commercial Labs’ Portion Of Bioassay Program

April 19, 1974

Richard Klausner resigned from the Gates Foundation, saying move was unrelated to Congressional investigation of NCI contract to Harvard University during Klausner’s tenure as NCI director.

September 16, 2005

Advisors say NCI needs to reach out to other fields.

July 15, 2005